Search
13/03/2023
Biofabrication of Self-Assembling Covalent Protein Nanoparticles through Histidine-Templated Cysteine Coupling
López-Laguna H., Rueda A., Martínez-Torró C., Sánchez-Alba L., Carratalá J.V., Atienza-Garriga J., Parladé E., Sánchez J.M., Serna N., Voltà-Durán E., Ferrer-Miralles N., Reverter D., Mangues R., Villaverde A., Vázquez E., Unzueta U.. Biofabrication of Self-Assembling Covalent Protein Nanoparticles through Histidine-Templated Cysteine Coupling. ACS Sustainable Chemistry & Engineering. 2023; 11(10)DOI:10.1021/acssuschemeng.2c06635. PMID:. IF:7.100(Q1/2D).
10/03/2023
Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes (vol 9, 1092688, 2023)
Egeberg A., Merola J.F., Schaekel, K, Puig L., Mahar P.D., Wang I.Y., Pavo I., Schuster C., Griffiths, CEM. Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes (vol 9, 1092688, 2023). Frontiers in Medicine. 2023; 10DOI:10.3389/fmed.2023.1171132. PMID:36974067. IF:3.100(Q1/2D).
10/03/2023
Obesity and fertility. Position statement.
Miñambres I, de Hollanda A, Vilarrasa N, Pellitero S, Rubio MA, Flores L, Caixàs A, Lobo S, Martinez Salamanca JI, Acevedo B, Moizé V, Andreu A, Escalada J. Obesity and fertility. Position statement.. Endocrinologia Diabetes y Nutricion. 2023; 70 Suppl 1DOI:10.1016/j.endien.2023.03.003. PMID:36907798. IF:(Q/D).
09/03/2023
Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis
Fehmi, J, Davies, AJ, Antonelou, M, Keddie, S, Pikkupeura, S, Querol, L, Delmont, E, Cortese, A, Franciotta, D, Persson, S, Barratt, J, Pepper, R, Farinha, F, Rahman, A, Canetti, D, Gilbertson, JA, Rendell, NB, Radunovic, A, Minton, T, Fuller, G, Murphy, SM, Carr, AS, Reilly, MR, Eftimov, F, Wieske, L, Teunissen, CE, Roberts, ISD, Ashman, N, Salama, AD, Rinaldi, S. Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis. PLoS One. 2023; 18(3)DOI:10.1371/journal.pone.0281156. PMID:36893151. IF:2.900(Q1/3D).
08/03/2023
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker
Martinez-Bosch, N, Vilarino, N, Alameda, F, Mojal, S, Arumi-Uria, M, Carrato, C, Aldecoa, I, Ribalta, T, Vidal, N, Bellosillo, B, Menendez, S, Del Barco, S, Gallego, O, Pineda, E, Lopez-Martos, R, Hernandez, A, Mesia, C, Esteve-Codina, A, de la Iglesia, N, Balana, C, Martinez-Garcia, M, Navarro, P. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker. Cells. 2023; 12(6)DOI:10.3390/cells12060843. PMID:36980184. IF:5.100(Q2/4D).
07/03/2023
Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding
Rudler, M, Hernandez-Gea, V, Procopet, BD, Giraldez, A, Amitrano, L, Villanueva, C, Ibanez, L, Silva, G, Genesca, J, Bureau, C, Trebicka, J, Banares, R, Krag, A, Llop, E, Laleman, W, Palazon, JM, Castellote, J, Rodrigues, S, Gluud, LL, Ferreira, CN, Canete, N, Rodriguez, M, Ferlitsch, A, Mundi, JL, Gronbaek, H, Hernandez-Guerra, M, Sassatelli, R, Dell'era, A, Senzolo, M, Abraldes, JG, Romero-Gomez, M, Zipprich, A, Casas, M, Masnou, H, Larrue, H, Primignani, M, Nevens, F, Calleja, JL, Schwarzer, R, Jansen, C, Robic, MA, Conejo, I, Gonzalez, JM, Catalina, MV, Albillos, A, Alvarado, E, Guardascione, MA, Mallet, M, Tripon, S, Casanovas, G, Bosch, J, Garcia-Pagan, JC, Thabut, D. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding. GUT. 2023; 72(4)DOI:10.1136/gutjnl-2022-326975. PMID:36328772. IF:23.100(Q1/1D).
07/03/2023
Association Between Orthostatic Hypotension and Dementia in Patients With Parkinson Disease and Multiple System Atrophy
Barrio, IR, Miki, Y, Jaunmuktane, ZT, Warner, T, De Pablo-Fernandez, E. Association Between Orthostatic Hypotension and Dementia in Patients With Parkinson Disease and Multiple System Atrophy. NEUROLOGY. 2023; 100(10)DOI:10.1212/WNL.0000000000201659. PMID:36526431. IF:8.400(Q1/1D).
02/03/2023
Antibodies against the flotillin-1/2 complex in patients with multiple sclerosis
Lleixà C., Caballero-Ávila M., Pascual-Goñi E., Martín-Aguilar L., Vidal N., Tejada C., Valdés-Hevia E., Zárate E., Vesperinas A., Collet R., Franco-Leyva T., Martínez-Martínez L., Moga E., Cortés-Vicente E., Rojas-García R., Gómez-Anson B., Gil A., González-Mingot C., Brieva L., Martínez-Yélamos S., Querol L.. Antibodies against the flotillin-1/2 complex in patients with multiple sclerosis. Brain Communications. 2023; 5(2)DOI:10.1093/braincomms/fcad109. PMID:37091585. IF:(Q/D).